Isogenica relocates its research facility to Chesterford Research Park

Cambridge UK, 18th February 2009

Isogenica Ltd, developer of innovative molecular evolution technologies, is re-locating its research facility to Chesterford Research Park, taking suites 5 and 6 plus additional laboratory space at the Mansion.

Isogenica had outgrown its previous location due to the company's expansion since it was founded in 2000 by CEO Kevin Fitzgerald. He said: 'We are a growing company and, due to a number of successful new business wins, we need additional space that will meet our needs both now and in the future. It's essential for us to have high quality labs combined with office space, which can be hard to find, but the Chesterford team came up with a suitable solution. Chesterford Research Park offers a fantastic location, with state-of-the-art facilities and good transport links.'

Extract from: Quested T “Double joy as Mansion House becomes full” Business Weekly - Cambridge, UK. 28 January 2009. Available from www.businessweekly.co.uk.

-Ends-

Press enquiries:

Kevin Matthews, Isogenica Ltd

M: +44 1799 533682
E: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Note to Editor

About Isogenica:
Isogenica specialises in providing protein engineering services using its core technology, “CIS display”, to pharmaceutical and biotechnology companies for the discovery, identification and design of new peptide, polypeptide and antibody lead compounds. The technology is adaptable for the display of different proteins and has been licensed for the Centyrin scaffold.
www.isogenica.com